Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rosalind Fabunmi"'
Autor:
Patricia A. Pellikka, Ratnasari Padang, Christopher G. Scott, Shannon M. E. Murphy, Rosalind Fabunmi, Jeremy J. Thaden
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 13 (2022)
Background Many patients with symptomatic severe aortic stenosis do not undergo aortic valve replacement (AVR) despite clinical guidelines. This study analyzed the association of managing provider type with cardiac specialist follow‐up, AVR, and mo
Externí odkaz:
https://doaj.org/article/901981420c334a539aa0b1fc92639d4d
Autor:
Patricia A Pellikka, Ratnasari Padang, Christopher Scott, Todd J Brinton, Shannon M Murphy, Rosalind Fabunmi, Jeremy J Thaden
Publikováno v:
Circulation. 144
A significant proportion of patients diagnosed with symptomatic severe aortic stenosis (ssAS) do not receive treatment with aortic valve replacement (AVR) despite current ACC/AHA guidelines. Delayed care leads to increased hospitalizations, worsening
Autor:
Kristin Taylor, Richard N. Bergman, Francesca Piccinini, Rosalind Fabunmi, Dongliang Zhuang, Terri Kim, Dennis Dong Hwan Kim
Publikováno v:
Diabetes. 68
ZGN-1061 is a second-generation methionine aminopeptidase 2 (MetAP2) inhibitor in development for treatment of T2D. Full results of a Phase 2 clinical trial of ZGN-1061 vs. placebo (PBO) administered SC for 12 weeks on change from baseline in A1C in
Publikováno v:
Methods in molecular medicine. 108
RNA interference (RNAi) is a form of posttranscriptional gene silencing in which the presence within the cell of double-stranded RNA (dsRNA) leads to the specific degradation of mRNA with a complimentary sequence. RNAi is a natural phenomenon that ca
Autor:
Rosalind Fabunmi, Loretta L. Nielsen, Ralph Quimbo, Brock Schroeder, Derek Misurski, Matthew Wintle, Ron Wade
Publikováno v:
Current Medical Research & Opinion; Mar2009, Vol. 25 Issue 3, p777-786, 10p